UiPath, Inc. (PATH) Spending and interest coverage
- R&D / revenue · 12 months: Value 21.40%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
- Stock-based compensation / revenue · 12 months: Value 13.63%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 21.40% | Research and development expense / revenue. Period ending 2026-07-31. $368.32M ÷ $1.72B × 100 ≈ 21.40% |
| Stock-based compensation / revenue · 12 months | 13.63% | Share-based compensation / revenue. Period ending 2026-07-31. $234.58M ÷ $1.72B × 100 ≈ 13.63% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 368.32M USD | Research and Development Expense |
| Revenue | 1.72B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 234.58M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 152.95M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $368.32M | $1.72B | $234.58M | $152.95M | (m) | 21.40% | 13.63% | (m) | (m) |
| 2026-04-30 | $383.27M | $1.67B | $267.63M | $101.16M | (m) | 22.92% | 16.00% | (m) | (m) |
| 2026-01-31 | $385.21M | $1.61B | $290.68M | $56.76M | (m) | 23.92% | 18.05% | (m) | (m) |
| 2025-10-31 | $389.72M | $1.55B | $313.47M | $10.08M | (m) | 25.09% | 20.18% | (m) | (m) |
| 2025-07-31 | $389.83M | $1.50B | $329.49M | $-46.35M | (m) | 26.05% | 22.01% | (m) | (m) |
| 2025-04-30 | $389.92M | $1.45B | $345.79M | $-129.52M | (m) | 26.87% | 23.83% | (m) | (m) |
| 2025-01-31 | $380.68M | $1.43B | $358.15M | $-162.57M | (m) | 26.63% | 25.05% | (m) | (m) |
| 2024-10-31 | $366.65M | $1.41B | $359.45M | $-181.08M | (m) | 25.98% | 25.47% | (m) | (m) |
| 2024-07-31 | $354.19M | $1.38B | $367.84M | $-193.54M | (m) | 25.62% | 26.61% | (m) | (m) |
| 2024-04-30 | $342.36M | $1.35B | $375.63M | $-167.77M | (m) | 25.29% | 27.75% | (m) | (m) |
| 2024-01-31 | $332.10M | $1.31B | $371.95M | $-164.72M | (m) | 25.39% | 28.44% | (m) | (m) |
| 2023-10-31 | $328.33M | $1.21B | $382.07M | $-224.96M | (m) | 27.10% | 31.54% | (m) | (m) |
| 2023-07-31 | $311.16M | $1.15B | $367.28M | $-236.13M | (m) | 27.10% | 31.99% | (m) | (m) |
| 2023-04-30 | $292.40M | $1.10B | $353.43M | $-278.74M | (m) | 26.51% | 32.04% | (m) | (m) |
| 2023-01-31 | $285.75M | $1.06B | $369.84M | $-348.28M | (m) | 26.99% | 34.94% | (m) | (m) |
| 2022-10-31 | $268.29M | $1.04B | $347.83M | $-354.01M | (m) | 25.80% | 33.45% | (m) | (m) |
| 2022-07-31 | $262.51M | $997.80M | $361.84M | $-403.27M | (m) | 26.31% | 36.26% | (m) | (m) |
| 2022-04-30 | $252.31M | $951.10M | $366.20M | $-380.90M | (m) | 26.53% | 38.50% | (m) | (m) |
| 2022-01-31 | $276.66M | $892.25M | $515.58M | $-500.95M | (m) | 31.01% | 57.78% | (m) | (m) |
| 2021-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-01-31 | $109.92M | $607.64M | $86.17M | $-110.32M | (m) | 18.09% | 14.18% | (m) | (m) |
| 2020-10-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-01-31 | $131.07M | $336.16M | $137.86M | $-517.28M | (m) | 38.99% | 41.01% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.